Fragrance composition

US12559703B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12559703-B2
Application numberUS-202117916949-A
CountryUS
Kind codeB2
Filing dateMay 4, 2021
Priority dateMay 5, 2020
Publication dateFeb 24, 2026
Grant dateFeb 24, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a fragrance composition, to a method for obtaining a fragrance composition, to a fragrance composition obtainable by such a method and to a use of such a fragrance composition.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A fragrance composition comprising: a) A mixture of fragrance ingredients consisting of: i. From 4 to 10 wt.-% of at least one fragrance ingredient having a volatility of 150 microgram/l or less at 25° C., defined as Group A ingredient; ii. From 20 to 36 wt.-% of at least one fragrance ingredient having a volatility of more than 150 microgram/l at 25° C. and at most 900 microgram/l at 25° C., defined as Group B ingredient; and iii. From 60 to 76 wt.-% of at least one fragrance ingredient having a volatility of more than 900 microgram/l at 25° C. defined as Group C ingredient; wherein 6 wt.-% or more of the mixture of fragrance ingredients comprises at least one Group C ingredient having an odor detection threshold of 1.5 ng/l or less, defined as Group C1 ingredient; and wherein the amounts of fragrance ingredients in wt.-% refer to the total weight of the mixture of fragrance ingredients; and b) optionally one or more technical ingredients. 2 . The fragrance composition according to claim 1 , wherein the at least one Group A ingredient is selected from the group consisting of: 3-phenylprop-2-enyl 3-phenylprop-2-enoate); 4-(4-hydroxyphenyl)butan-2-one); methyl 2,4-dihydroxy-3,6-dimethylbenzoate); 3,8,8,11a-tetramethyldodecahydro-1H-3,5a-epoxynaphtho[2,1-c]oxepine); (Z)-cycloheptadec-9-enone); 1,4-dioxacycloheptadecane-5,17-dione); benzyl 2-hydroxybenzoate); 1,4-dioxacyclohexadecane-5,16-dione); (2E,6Z)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol); (4E)-9-hydroxy-5,9-dimethyl-4-decenal); 2-phenethyl 2-hydroxybenzoate); 3-ethoxy-4-hydroxybenzaldehyde); 4-formyl-2-methoxyphenyl isobutanoate); 3-((1R,2S,4R,6R)-5,5,6-trimethylbicyclo[2.2.1]heptan-2-yl)cyclohexanol); 4,6,6,7,8,8-hexamethyl-1,3,4,6,7,8-hexahydrocyclopenta[g]isochromene); 2-(2-(3,3,5-trimethylcyclohexyl)acetyl)cyclopentanone); 2-(1-(3,3-dimethylcyclohexyl)ethoxy)-2-methylpropyl cyclopropanecarboxylate); (Z)-oxacycloheptadec-10-en-2-one); (4aR,5R,7aS,9R)-Octahydro-2,2,5,8,8,9a-hexamethyl-4H-4a,9-methanoazuleno[5,6-d]-1,3-dioxole); 1-oxacycloheptadecan-2-one); 2-cyclohexylidene-2-phenylacetonitrile); 2-cyclohexylidene-2-phenylacetonitrile); (E)-2-benzylideneoctanal); 2-hexylcyclopent-2-enone); 5-octyloxolan-2-one); (Z)-cyclohexadec-5-enone); 6-heptyltetrahydro-2H-pyran-2-one); (E)-oxacyclohexadec-12-en-2-one); cyclopentadecanone); 5-(sec-butyl)-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane); 1-(2-naphtalenyl)-ethanone); 2,2,2-trichloro-1-phenylethyl acetate); 2,4-dimethyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-1,3-dioxolane); 6-hexyltetrahydro-2H-pyran-2-one); (Z)-3-methylcyclopentadec-5-enone); diphenylmethanone); oxacyclohexadecan-2-one); ((1S,8aR)-1,4,4-trimethyl-2,3,3a,4,5,8-hexahydro-1H-5,8a-methanoazulen-6-yl)methanol); (1-methyl-2-((1,2,2-trimethylbicyclo[3.1.0]hexan-3-yl)methyl)cyclopropyl)methanol); methyl 3-oxo-2-pentylcyclopentaneacetate); 2H-chromen-2-one); 3-(benzo[d][1,3]dioxol-5-yl)-2-methylpropanal); (3E,6E)-2,4,4,7-tetramethylnona-6,8-dien-3-one oxime); 1-(2,2,6-trimethylcyclohexyl)hexan-3-ol); 2-ethyl-3-hydroxy-4H-pyran-4-one); 3-hydroxy-2-methyl-4H-pyran-4-one); 1-((1S,8aS)-1,4,4,6-tetramethyl-2,3,3a,4,5,8-hexahydro-1H-5,8a-methanoazulen-7-yl)ethanone); 1-((1S,8aS)-1,4,4,6-tetramethyl-2,3,3a,4,5,8-hexahydro-1H-5,8a-methanoazulen-7-yl)ethanone); (7,7,8,8-tetramethyloctahydro-2,3b-methanocyclopenta[1,3]cyclopropa[1,2]benzen-4-yl)methyl acetate); (1S,6R,8aR)-1,4,4,6-tetramethyloctahydro-1H-5,8a-methanoazulen-6-yl acetate); hexyl 2-hydroxybenzoate); (Z)-3-methylcyclotetradec-5-enone); 3a-ethyl-6,6,9a-trimethyldodecahydronaphtho[1,2-c]furan); (E)-13-methyloxacyclopentadec-10-en-2-one); (E)-2-ethyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol); (4Z)-hept-4-en-2-yl 2-hydroxybenzoate); 2-(3,8-dimethyl-1,2,3,4,5,6,7,8-octahydroazulen-5-yl)propan-2-yl acetate); 3-(4-isobutyl-2-methylphenyl)propanal); 3-methyl-5-phenylpentan-1-ol); (E)-2-methoxy-4-(prop-1-en-1-yl)phenol); (1-methyl-2-(((1R,3R)-2,2,3-trimethylcyclopentyl)methyl)cyclopropyl)methanol); 3-methoxy-5-methylphenol); (Z)-6-(pent-2-en-1-yl)tetrahydro-2H-pyran-2-one); 3-(4-(tert-butyl)phenyl)-2-methylpropanal); (E)-2-methyl-4-(2,2,3-trimethyl-1-cyclopent-3-enyl)but-2-en-1-ol); 4-allyl-2-methoxyphenyl acetate); (E)-3-phenylprop-2-en-1-ol); 3-methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pentan-2-ol); (E)-tridec-2-enenitrile); (E)-1,2-dimethoxy-4-(prop-1-en-1-yl)benzene); (4Z,8Z)-1,5,9-trimethyl-13-oxabicyclo[10.1.0]trideca-4,8-diene); 6-pentyltetrahydro-2H-pyran-2-one); 4,8a,9,9-tetramethyldecahydro-1,6-methanonaphthalen-1-ol); (ethoxymethoxy)cyclododecane); (E)-2-methyl-4-(2,2,3-trimethyl-1-cyclopent-3-enyl)but-2-en-1-ol); octahydro-2H-chromen-2-one); 2-methoxynaphthalene); 1-(2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone); 1-(2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone); 1-(1,2,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone); (4-methoxyphenyl)methanol); 2-ethoxynaphthalene); 5-hexyloxolan-2-one); (E)-2-((3,5-dimethylhex-3-en-2-yl)oxy)-2-methylpropyl cyclopropanecarboxylate); 3-(4-methoxyphenyl)-2-methylpropanal); (E)-6,10-dimethylundeca-5,9-dien-2-yl acetate); N-ethyl-N-(m-tolyl)propionamide); 6-butan-2-yl-quinoline); 2,2-dimethyl-3-(m-tolyl)propan-1-ol); 7,9-dimethylspiro[5.5]undecan-3-one); (E)-3-phenylprop-2-en-1-yl acetate); 3-(4-(tert-butyl)phenyl)propanal); ethyl methyl phenyl glycidate); 2,4a,5,8a-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl formate); 4-methyl-5-pentyldihydrofuran-2 (3H)-one); (E)-3,3-dimethyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-2-ol); (E)-4-((3aS,7aS)-hexahydro-1H-4,7-methanoinden-5 (6H)-ylidene)butanal); 1-((2-(tert-butyl)cyclohexyl)oxy)butan-2-ol); (E)-3-methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pent-4-en-2-ol); 7-methyl-2H-benzo[b][1,4]dioxepin-3 (4H)-one); pentyl 2-hydroxybenzoate); 2,6,10-trimethylundec-9-enal); 1a,3,3,4,6,6-hexamethyl-1a,2,3,4,5,6,7,7a-octahydronaphtho[2,3-b]oxirene); 7-methoxy-3,7-dimethyloctan-2-ol); (E)-4-(2,5,6,6-tetramethylcyclohex-2-en-1-yl)but-3-en-2-one); benzo[d][1,3]dioxole-5-carbaldehyde); (1R,2S,4R)-2′-isopropyl-1,7,7-trimethylspiro[bicyclo[2.2.1]heptane-2,4′-[1,3]dioxane]); dodecanenitrile); ethyl 6-acetoxyhexanoate); 3-(4-isopropylphenyl)-2-methylpropanal); (1R,6S,8aS)-6-methoxy-1,4,4,6-tetramethyloctahydro-1H-5,8a-methanoazulene); 4-(4-methylpent-3-en-1-yl)cyclohex-3-enecarbaldehyde); 5-pentyldihydrofuran-2 (3H)-one); 4,4a,5,9b-tetrahydroindeno[1,2-d][1,3]dioxine); dec-9-en-1-ol); (1-methyl-2-(5-methylhex-4-en-2-yl)cyclopropyl)methanol); 2-cyclohexylhepta-1,6-dien-3-one); (Z)-1-(cyclooct-3-en-1-yl)propan-1-ol); decan-1-ol); 3-(3-isopropylphenyl)butanal); methyl 3-phenylprop-2-enoate); 8-(sec-butyl)-5,6,7,8-tetrahydroquinoline); 3-phenylpropan-1-ol); (E)-undec-9-enenitrile); 2′,2′,3,7,7-pentamethylspiro[bicyclo[4.1.0]heptane-2,5′-[1,3]dioxane]); 4-(1-ethoxyvinyl)-3,3,5,5-tetramethylcyclohexanone); 2-methoxy-4-propylphenol); 2-methyl-4-phenylbutan-2-ol); 2-methyl-1-phenylpropan-2-yl butanoate); (E)-3-phenylprop-2-enenitrile); tetrahydro-4-methyl-2-(2-methylpropyl)-2H-pyran-4-ol); methyl 2-aminobenzoate); 3-(4-ethylphenyl)-2,2-dimethylpropanal); (E)-7,11-dimethyl-3-methylenedodeca-1,6,10-triene); (3aR,6S,7aS)-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl propionate); 6-propyltetrahydro-2H-pyran-2-one); 4-allyl-2-methoxyphenol); 1-(3,3-dimethylcyclohex-1-en-1-yl)pent-4-en-1-one); 1,1,2,3,3-pentamethyl-2,3,6,7-tetrahydro-1H-inden-4 (5H)-one); 4-(tert-butyl)cyclohexanol); methyl 2-(methylamino)benzoate); (E)-3,7-dimethylocta-2,6-dien-1-ol); (E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-one); dodecanal); 3,7-dimethyloct-6-en-1-ol); 2-isopropyl-5-methylphenol); (E)-3-phenylprop-2-en-1-ol); allyl 3-cyclohexylpropionate); 4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-one); (2E)-3-phenylprop-2-enal); diphenylmethane); (E)-3-methyl-4-(2,6,6-trimethylcyclohex-2-en-

Assignees

Inventors

Classifications

  • Mixtures with anionic, cationic or non-ionic compounds · CPC title

  • Hard surfaces · CPC title

  • Mixtures of anionic, cationic, and non-ionic compounds · CPC title

  • C11D3/50Primary

    Perfumes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12559703B2 cover?
The present invention relates to a fragrance composition, to a method for obtaining a fragrance composition, to a fragrance composition obtainable by such a method and to a use of such a fragrance composition.
Who is the assignee on this patent?
Givaudan Sa
What technology area does this patent fall under?
Primary CPC classification C11D3/50. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).